RxDoctor Payments Data

Talha Farid, MD

Clinical Cardiac Electrophysiology · Cedar Rapids, IANPI 1396090353

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (44.6%), grants and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Medtronic at 34.9% of the total. Reporting peaked in 2019 at $7,726 and has fallen 80.9% since, to $1,476 in 2025.

$17,054in general payments, 2019–2025

Across 136 payments — averaging $125.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$6K
  • Boston Scientific$5K
  • Abbott$5K
  • Impulse Dynamics (USA) Inc.$360
  • GE HealthCare$107
  • Philips North America LLC$89
  • plus $93 from 3 others

What the payments were for

  • Grants$5,00029%
  • Travel & lodging$7,60845%
  • Food & beverage$3,94923%
  • Education$4973%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,054 in reported general payments places this provider in the 55th percentile of 42 clinical cardiac electrophysiology providers in Iowa.

See all clinical cardiac electrophysiology providers in Iowa

Medicare billing

Part B allowed, 2024
$382,061
Medicare patients
1,062
Services billed
3,924

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban679$736,857
XareltoRivaroxaban252$267,179
MultaqDronedarone Hcl21$23,178
Flecainide Acetate219$10,103
Metoprolol Succinate763$8,150
SotalolSotalol Hcl459$6,771
Dabigatran EtexilateDabigatran Etexilate Mesylate14$4,853
Diltiazem 24hr Er (Cd)Diltiazem Hcl273$4,701
Dofetilide16$3,451
Amiodarone Hcl241$3,155
Potassium Chloride54$1,264
Digoxin23$734
Diltiazem 24hr ErDiltiazem Hcl15$540
ClopidogrelClopidogrel Bisulfate100$508
Pantoprazole Sodium113$438

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Cedar Rapids

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →